| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/27/2013 | CN102335373B Chinese medicinal composition for treating upper respiratory tract infection, and preparation method thereof |
| 03/27/2013 | CN102335284B Externally applied health care product for recovery of female cauliflower excrescence |
| 03/27/2013 | CN102335198B Production method for tick-borne encephalitis virus horse antiserum |
| 03/27/2013 | CN102327608B Purifying method of encephalitis B vaccine |
| 03/27/2013 | CN102327392B Formula of Chinese medicine for treating viral pneumonia |
| 03/27/2013 | CN102327240B Cefbuperazone sodium medicinal composite for injection and preparation method thereof |
| 03/27/2013 | CN102319255B Anti-radiation spriulina polysaccharide organic bio-active iodine and application thereof |
| 03/27/2013 | CN102304555B Preparation method and application of antibiotics lobophorin A and lobophorin B |
| 03/27/2013 | CN102302460B Methylprednisolone sodium succinate freeze dried powder injection and preparation method thereof |
| 03/27/2013 | CN102293979B Use of traditional Chinese medicine composition in preparation of antiviral drugs |
| 03/27/2013 | CN102293890B Pharmaceutical composition for treating beriberi, tinea pedis, smelly feet or sweaty feet |
| 03/27/2013 | CN102283824B Medicinal composition and soft capsule preparation for treating influenza |
| 03/27/2013 | CN102274330B Medicament for treating beriberi |
| 03/27/2013 | CN102258774B Preparation method of Brucellosis live vaccine and product thereof |
| 03/27/2013 | CN102258548B Method for preparing nardostachyos root and rhizome volatile oil beta-cyclodextrin inclusion compound |
| 03/27/2013 | CN102247319B Thymalfasin-containing medicinal composition and preparation method thereof |
| 03/27/2013 | CN102234638B Modified maize ribosome-inactivating protein precursor and application as well as protein purification method thereof |
| 03/27/2013 | CN102206247B Novel peptides as NS3/NS4a serine protease inhibitors of hepatitis C virus |
| 03/27/2013 | CN102199217B Hepatitis B virus multi-epitope fusion protein and preparation method and application thereof |
| 03/27/2013 | CN102190726B Fab segment of human HIV antibody, and coding gene and application thereof |
| 03/27/2013 | CN102188594B Preparation method of traditional Chinese medicine for treating pharyngalgia pediatric influenza |
| 03/27/2013 | CN102180853B Anti-enterovirus 71 (EV71) flavonoid compound and application thereof to pharmacy |
| 03/27/2013 | CN102167736B Green mud crab antibacterial peptide Sphistin and application thereof |
| 03/27/2013 | CN102166276B Traditional Chinese medicine composition for preventing and treating influenza A and preparation method and application thereof |
| 03/27/2013 | CN102160893B Taxus polysaccharide immunologic adjuvant and influenza vaccine containing same |
| 03/27/2013 | CN102153555B Carbapenem compound containing amido formacyl heterocycle |
| 03/27/2013 | CN102140130B Antibacterial peptide and use thereof |
| 03/27/2013 | CN102138922B Cefcapene pivoxil hydrochloride composition and preparation method thereof |
| 03/27/2013 | CN102133178B Clindamycin phosphate injection and preparation method thereof |
| 03/27/2013 | CN102114044B Artificially processed bear bile powder and preparation method thereof |
| 03/27/2013 | CN102100850B Quality control method for refined fructus forsythiae antidotal tablets |
| 03/27/2013 | CN102099375B Anti-idiotypic monoclonal antibody against envelope protein vp28 of shrimp white spot syndrome virus and the preparation method thereof |
| 03/27/2013 | CN102091299B Method for detecting medicinal composition for treating viral hepatitis |
| 03/27/2013 | CN102046173B Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid |
| 03/27/2013 | CN101991848B Synthetic peptide vaccine for swine fever and application thereof |
| 03/27/2013 | CN101984061B Vaccine strains of infectious clones of porcine reproductive and respiratory syndrome virus (PRRSV) and application thereof |
| 03/27/2013 | CN101974472B Marker-free gene deletion attenuated mutant strain of Edwardsiella tarda wild strain as well as relevant preparations and application thereof |
| 03/27/2013 | CN101928728B Method for preparing enterovirus virus-like particle and application thereof |
| 03/27/2013 | CN101921772B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101906464B Proteins producing an altered immunogenic response and methods of making and using the same |
| 03/27/2013 | CN101897953B Non-invasive high-penetrability epidermal growth factor and application thereof |
| 03/27/2013 | CN101890023B Cefuroxime axetil oral liquid and preparation method thereof |
| 03/27/2013 | CN101829082B Method for preparing veterinary injection of spectinomycin hydrochloride and lincomycin hydrochloride |
| 03/27/2013 | CN101808651B Polymer conjugate of steroid |
| 03/27/2013 | CN101797299B Refining method of traditional Chinese medicine composition water extract liquid containing fructus forsythiae |
| 03/27/2013 | CN101797241B Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
| 03/27/2013 | CN101791410B Preparation and application of conjugate of anti-infective medicament and polysaccharide and medicinal composition thereof |
| 03/27/2013 | CN101757072B Method for enriching and purifying rhizoma atractylodis volatile oil in rhizoma atractylodis |
| 03/27/2013 | CN101744926B Chinese medicinal antibacterial lotion and preparation method thereof |
| 03/27/2013 | CN101732706B Method for preparing living paratyphoid vaccine for piglets and product thereof |
| 03/27/2013 | CN101637533B Application of Chinese medicinal composition in preparation of medicament for treating virus myocarditis |
| 03/27/2013 | CN101637529B Application of Chinese medicinal composition in preparation of medicament for treating hand-foot-and-mouth disease |
| 03/27/2013 | CN101613352B Carbapenem derivatives containing formamide heterocyclic mercaptopyrrolidine |
| 03/27/2013 | CN101600726B Novel nucleoside analogs for treatment of viral infections |
| 03/27/2013 | CN101573344B Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same |
| 03/27/2013 | CN101528777B Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 03/27/2013 | CN101381409B N-terminally chemically modified protein compositions and methods |
| 03/27/2013 | CN101370783B Salts of 1-alkylamino-1-desoxypolyols with 9-oxoacridine-10-acetic acid, medicinal preparations on base, use, preventive measures and treatment thereof |
| 03/27/2013 | CN101294159B Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection |
| 03/27/2013 | CN101277950B Inhibitors of serine proteases |
| 03/27/2013 | CN101252920B Stable fixed-dose unitary formulations containing tenofovir, a surfactant, efavirenz and emtricitabine |
| 03/27/2013 | CN101175404B Method and composition for use in preparation of a patient for surgery |
| 03/27/2013 | CN101128427B Heterocyclic compounds as ccr2b antagonists |
| 03/27/2013 | CN101066997B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101014624B Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |
| 03/26/2013 | US8404852 Gyrase inhibitors and uses thereof |
| 03/26/2013 | US8404826 Mycobacterial antigens expressed under low oxygen tension |
| 03/26/2013 | US8404805 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 03/26/2013 | US8404737 Substituted isoindoline-1,3-dione derivatives |
| 03/26/2013 | US8404704 Use of polymorphic forms of rifaximin for medical preparations |
| 03/26/2013 | US8404676 Oxadiazole diaryl compounds |
| 03/26/2013 | US8404671 Heterosubstituted N-thiolated beta-lactam compounds and methods of use |
| 03/26/2013 | US8404633 CD5 pharmaceutical compositions for the treatment of infectious and inflammatory processes of fungal origin |
| 03/26/2013 | US8404265 Contact lenses for extended release of bioactive agents containing diffusion attenuators |
| 03/26/2013 | US8404250 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/26/2013 | CA2791142A1 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
| 03/26/2013 | CA2579141C Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 03/26/2013 | CA2551602C Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| 03/26/2013 | CA2495938C A wide spectrum disinfectant |
| 03/26/2013 | CA2457925C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 03/26/2013 | CA2395197C Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 03/21/2013 | WO2013040577A1 Aptamers resistant to nucleocapsid degradation |
| 03/21/2013 | WO2013040564A2 Antibody recognizing arbitrarily designed epitope of three or more amino acid residues in a peptide and method of generating thereof |
| 03/21/2013 | WO2013040269A1 Products for healing of tissue wounds |
| 03/21/2013 | WO2013040265A1 Compositions for treating bone diseases and broken bones |
| 03/21/2013 | WO2013040233A1 Controlling regulatory t cell function |
| 03/21/2013 | WO2013040040A1 Peptides mimicking hiv-1 viral epitopes in the v2 loop for the gp120 surface envelope glycoprotein |
| 03/21/2013 | WO2013039947A1 Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide |
| 03/21/2013 | WO2013039855A1 Compounds and pharmaceutical compositions for the treatment of viral infections |
| 03/21/2013 | WO2013039202A1 Novel acrylic acid derivative |
| 03/21/2013 | WO2013039069A1 Novel recombinant bcg vaccine |
| 03/21/2013 | WO2013038997A1 Pharmaceutical composition and manufacturing method therefor |
| 03/21/2013 | WO2013038430A1 SYNTHESIS OF 10-α/β-D-ARABINOFURANOSYL-UNDECENES AS POTENTIAL ANTI-MYCOBACTERIAL AGENTS |
| 03/21/2013 | WO2013038407A1 Amorphous form of dolutegravir |
| 03/21/2013 | WO2013038385A2 Escherichia coli vaccine combination |
| 03/21/2013 | WO2013038330A1 Nitrogen containing compounds and their use |
| 03/21/2013 | WO2013038259A1 Benzothiazinone derivatives as anti -tuberculosis agents |
| 03/21/2013 | WO2013038156A1 Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile |
| 03/21/2013 | WO2013037894A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group |
| 03/21/2013 | WO2013037859A1 Compositions for the treatment of peripheral ulcers of various origins |